| 1.1 Absolute change in per cent predicted FEV1 |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 1.1.1 Up to 2 weeks |
1 |
24 |
Mean Difference (IV, Fixed, 95% CI) |
8.70 [2.32, 15.08] |
| 1.1.2 Up to 12 weeks |
1 |
24 |
Mean Difference (IV, Fixed, 95% CI) |
8.10 [0.45, 15.75] |
| 1.2 Absolute change in per cent predicted FVC |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 1.2.1 Up to 2 weeks |
1 |
24 |
Mean Difference (IV, Fixed, 95% CI) |
12.81 [4.73, 20.89] |
| 1.2.2 Up to 12 weeks |
1 |
24 |
Mean Difference (IV, Fixed, 95% CI) |
6.70 [‐2.12, 15.52] |
| 1.3 Growth retardation (at 4 years) |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 1.3.1 1 mg prednisone |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 1.3.2 2 mg prednisone |
1 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 1.4 Height at age over 18 years (boys) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.4.1 1 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.4.2 2 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.5 Height at over 18 years (girls) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.5.1 1 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.5.2 2 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.6 Absolute change in weight (kg) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.6.1 Up to 12 weeks |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.7 Weight at over 18 years (boys) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.7.1 1 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.7.2 2 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.8 Weight at over 18 years (girls) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.8.1 1 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.8.2 2 mg prednisone |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 1.9 Adverse events |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.1 Cataracts (1 mg prednisone) (up to 4 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.2 Cateracts (2 mg prednisone) (up to 3 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.3 Diabetes mellitus (1 mg prednisone) (up to 4 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.4 Diabetes mellitus (2 mg prednisone) (up to 3 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.5 Glucosoria (1 mg prednisone) (up to 4 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.6 Glucosoria (2 mg prednisone) (up to 3 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.7 Hyperglycemia (1 mg prednisone) (up to 4 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.9.8 Hyperglycemia (2 mg prednisone) (up to 3 years) |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.10 Mortality |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
| 1.10.1 At 4 years |
1 |
|
Peto Odds Ratio (Peto, Fixed, 95% CI) |
Totals not selected |
